Lutz Buellesfeld

Lutz Buellesfeld

Auto-generated profile, based on publicly available information

Lutz Buellesfeld

Department of Cardiology/Angiology, HELIOS Heart Center Siegburg, Ringstrasse 49, 53721 Siegburg, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2009 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LBLutz Buellesfeld
Lutz Buellesfeld
PWPeter Wenaweser
Peter Wenaweser
UGUlrich Gerckens
Ulrich Gerckens
RMRalf Mueller
Ralf Mueller
BSBarthel Sauren
Barthel Sauren
EGEberhard Grube
Eberhard Grube
The purpose of the present analysis was to identify predictors of procedural success of percutaneous transcatheter aortic valve implantation (TAVI). We prospectively assessed in-hospital outcome of patients undergoing TAVI at two institutions. We analysed clinical, morphological, and procedural parameters using univariate and multivariate regression models. Between 2005 and 2008, a total of 168 consecutive patients with symptomatic aortic valve stenosis underwent TAVI using the self-expanding CoreValve Revalving prosthesis. Patients (93%) were highly symptomatic with a New York Heart Association grade III/IV and a mean aortic valve area of 0.66 ± 0.21 cm2. Acute and in-hospital procedural success rates were 90.5 and 83.9%, respectively, with an in-hospital mortality, myocardial infarction, and stroke rate of 11.9, 1.8, and 3.6%, respectively. Predictors of in-hospital procedural success were type of access (OR 0.33, 95% CI 0.13–0.82, P = 0.017), prior coronary intervention (OR 5.3, 95% CI 1.20–23.41, P = 0.028) and pre-procedural Karnofsky index using univariate regression. Pre-procedural Karnofsky index emerged as the only independent predictor (OR 1.04, 95% CI 1.00–1.08, P = 0.032) in the multivariate analysis. Pre-procedural functional performance status predicts the in-hospital outcome after TAVI. Patients with a good functional status are likely to benefit more from TAVI than previously reported high-risk patients.